889947-54-0 Usage
Uses
Used in Pharmaceutical Synthesis:
(R)-tert-butyl 2-(4-aminophenyl)pyrrolidine-1-carboxylate is used as a chiral building block for the synthesis of various pharmaceuticals. Its unique structure allows for the creation of enantiomerically pure compounds, which are essential in the development of drugs with specific therapeutic effects and minimal side effects.
Used in Organic Chemistry:
In the field of organic chemistry, (R)-tert-butyl 2-(4-aminophenyl)pyrrolidine-1-carboxylate serves as an important intermediate. Its presence in the synthesis process aids in the production of a range of fine chemicals, contributing to the diversity and complexity of chemical compounds that can be created.
Used in Drug Development:
(R)-tert-butyl 2-(4-aminophenyl)pyrrolidine-1-carboxylate is also utilized in drug development as a key intermediate. Its role in the synthesis of various drugs highlights its significance in the pharmaceutical industry, where it contributes to the advancement of new and improved medications.
Used in the Production of Enantiomerically Pure Compounds:
(R)-tert-butyl 2-(4-aminophenyl)pyrrolidine-1-carboxylate is used as a precursor for the production of enantiomerically pure compounds, which are vital in the pharmaceutical industry. The ability to create these pure compounds allows for more targeted and effective treatments, reducing the risk of adverse effects associated with less specific medications.
Check Digit Verification of cas no
The CAS Registry Mumber 889947-54-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,9,9,4 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 889947-54:
(8*8)+(7*8)+(6*9)+(5*9)+(4*4)+(3*7)+(2*5)+(1*4)=270
270 % 10 = 0
So 889947-54-0 is a valid CAS Registry Number.
889947-54-0Relevant academic research and scientific papers
Barker, Graeme,Obrien, Peter,Campos, Kevin R.
, p. 4176 - 4179 (2010)
A diamine-free protocol for the s-BuLi-mediated lithiation-trapping of N-Boc heterocycles has been developed. In the optimized procedure, lithiation is accomplished using s-BuLi in THF at -30 °C for only 5 or 10 min. Subsequent electrophilic trapping or transmetalation-Negishi coupling delivered a range of functionalized pyrrolidines, imidazolidines, and piperazines in 43-83% yield.
TANK-BINDING KINASE INHIBITOR COMPOUNDS
-
Paragraph 1936, (2016/05/02)
Compounds having the following formula (I) and methods of their use and preparation are disclosed:
